Compounds > hydrogen

hydrogen and rifamycins

hydrogen has been researched along with rifamycins in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (6.67)	18.7374
1990's	1 (6.67)	18.2507
2000's	8 (53.33)	29.6817
2010's	4 (26.67)	24.3611
2020's	1 (6.67)	2.80

Authors

Authors	Studies
Naganawa, H; Xiao-Chang, F	1
Bergami, R; Ferrieri, A; Roda, E; Ventrucci, M	1
Corazza, GR; Di Stefano, M; Ferrieri, A; Malservisi, S; Veneto, G	1
Corazza, GR; Di Stefano, M; Ferrieri, A; Malservisi, S; Strocchi, A; Veneto, G	1
Corazza, GR; Di Stefano, M; Mazzocchi, S; Miceli, E; Missanelli, A	1
Agostini, D; Biancone, L; Ferrieri, A; Pallone, F; Vernia, P	1
Abdul-Baki, H; Aoun, E; Elhajj, I; Mounzer, R; Sharara, AI; Sidani, S	1
D'Incà, R; Dal Pont, E; Di Leo, V; Ferronato, A; Medici, V; Pomerri, F; Sturniolo, GC; Vettorato, MG	1
Foran, P; Majewski, M; McCallum, RW; Reddymasu, SC; Sostarich, S	1
Bilotta, AL; Cammarota, G; Gabrielli, M; Gasbarrini, A; Gasbarrini, G; Laginestra, A; Lauritano, EC; Lupascu, A; Novi, M; Pontecorvi, A; Scarpellini, E; Serricchio, M; Sottili, S	1
Chiecchio, A; Foti, M; Lombardo, L; Ruggia, O	1
Akopian, G; Coloma, E; Fernández, M; Kaufman, HS; Ortega, A; Petrone, P; Sarkisyan, G	1
Chang, MS; Cheng, J; Connor, BA; Green, PH; Lewis, SK; Minaya, MT	1
Harris, LA	1
Chan, WW; Muratore, A; Shah, ED	1

Trials

7 trial(s) available for hydrogen and rifamycins

Article	Year
Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Breath Tests; Chlortetracycline; Double-Blind Method; Female; Gastrointestinal Agents; Humans; Hydrogen; Intestine, Small; Male; Middle Aged; Rifamycins; Rifaximin; Treatment Outcome	2000
Non-absorbable antibiotics for managing intestinal gas production and gas-related symptoms. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:8 Topics: Absorption; Adult; Aged; Charcoal; Double-Blind Method; Female; Flatulence; Gastrointestinal Agents; Humans; Hydrogen; Male; Middle Aged; Rifamycins; Rifaximin; Treatment Outcome	2000
Effect of rifaximin on intestinal bacterial overgrowth in Crohn's disease as assessed by the H2-Glucose Breath Test. Current medical research and opinion, 2000, Volume: 16, Issue:1 Topics: Adult; Anti-Infective Agents; Bacterial Infections; Breath Tests; Crohn Disease; Female; Gastrointestinal Agents; Humans; Hydrogen; Ileum; Male; Middle Aged; Placebos; Rifamycins; Rifaximin; Treatment Outcome	2000
A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. The American journal of gastroenterology, 2006, Volume: 101, Issue:2 Topics: Adult; Breath Tests; Double-Blind Method; Female; Flatulence; Follow-Up Studies; Gastrointestinal Agents; Humans; Hydrogen; Lactulose; Male; Rifamycins; Rifaximin; Treatment Outcome	2006
Interaction between rifaximin and dietary fibre in patients with diverticular disease. Alimentary pharmacology & therapeutics, 2007, Apr-01, Volume: 25, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Breath Tests; Cross-Over Studies; Dietary Fiber; Diverticulum; Double-Blind Method; Drug Interactions; Female; Follow-Up Studies; Gastrointestinal Transit; Humans; Hydrogen; Male; Middle Aged; Patient Compliance; Rifamycins; Rifaximin	2007
Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth. The American journal of the medical sciences, 2007, Volume: 333, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Breath Tests; Female; Gastrointestinal Agents; Gastrointestinal Diseases; Humans; Hydrogen; Intestine, Small; Male; Methane; Middle Aged; Rifamycins; Rifaximin; Treatment Outcome	2007
Double-blind randomized controlled trial of rifaximin for persistent symptoms in patients with celiac disease. Digestive diseases and sciences, 2011, Volume: 56, Issue:10 Topics: Adult; Breath Tests; Celiac Disease; Double-Blind Method; Female; Gastrointestinal Agents; Humans; Hydrogen; Lactulose; Male; Middle Aged; Regression Analysis; Rifamycins; Rifaximin; Treatment Outcome	2011

Other Studies

8 other study(ies) available for hydrogen and rifamycins

Article	Year
1H NMR analysis of R-75-1 substance. The Japanese journal of antibiotics, 1981, Volume: 34, Issue:6 Topics: Hydrogen; Magnetic Resonance Spectroscopy; Molecular Conformation; Rifamycins	1981
Evaluation of the effect of rifaximin in colon diverticular disease by means of lactulose hydrogen breath test. Current medical research and opinion, 1994, Volume: 13, Issue:4 Topics: Adult; Aged; Breath Tests; Diverticulum, Colon; Female; Humans; Hydrogen; Lactulose; Lung; Male; Middle Aged; Rifamycins	1994
Absorbable vs. non-absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome. Alimentary pharmacology & therapeutics, 2005, Apr-15, Volume: 21, Issue:8 Topics: Anti-Bacterial Agents; Blind Loop Syndrome; Breath Tests; Humans; Hydrogen; Intestinal Absorption; Metronidazole; Rifamycins; Rifaximin	2005
Association between hypothyroidism and small intestinal bacterial overgrowth. The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:11 Topics: Adult; Anti-Bacterial Agents; Bacteria; Breath Tests; Data Interpretation, Statistical; Decontamination; Female; Gastrointestinal Agents; Humans; Hydrogen; Hypothyroidism; Intestine, Small; Male; Rifamycins; Rifaximin; Thyroid Hormones	2007
Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2010, Volume: 8, Issue:6 Topics: Adult; Anti-Bacterial Agents; Bacteria; Blind Loop Syndrome; Breath Tests; Female; Gastroesophageal Reflux; Glucose; Humans; Hydrogen; Incidence; Intestine, Small; Irritable Bowel Syndrome; Male; Middle Aged; Proton Pump Inhibitors; Rifamycins; Rifaximin; Treatment Outcome	2010
Small intestinal bacterial overgrowth in patients with lower gastrointestinal symptoms and a history of previous abdominal surgery. Archives of surgery (Chicago, Ill. : 1960), 2011, Volume: 146, Issue:4 Topics: Adult; Aged; Anti-Infective Agents; Bacteria; Breath Tests; Diagnosis, Differential; Digestive System Surgical Procedures; Female; Gastrointestinal Agents; Gastrointestinal Tract; Gram-Negative Bacteria; Helicobacter pylori; Humans; Hydrogen; Hydrogen-Ion Concentration; Intestine, Small; Irritable Bowel Syndrome; Logistic Models; Male; Methane; Middle Aged; Research Design; Retrospective Studies; Rifamycins; Rifaximin; Sample Size	2011
Rifaximin for Irritable Bowel Syndrome (IBS) in Gulf War Veterans: Losing the Battle but Winning the War? Digestive diseases and sciences, 2019, Volume: 64, Issue:3 Topics: Breath Tests; Double-Blind Method; Gulf War; Humans; Hydrogen; Irritable Bowel Syndrome; Lactulose; Rifamycins; Rifaximin; Veterans	2019
Cost-Benefit Analysis of Hydrogen Breath Test-Directed Rifaximin for Treatment of Diarrhea-Predominant Irritable Bowel Syndrome. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2023, Volume: 21, Issue:10 Topics: Breath Tests; Cost-Benefit Analysis; Diarrhea; Humans; Hydrogen; Irritable Bowel Syndrome; Rifamycins; Rifaximin	2023